|
 |
| home > epc > winter 2002 > meeting new pharmacovigilance challenges - the need for outsourcing |
 |
 |
PUBLICATIONS |
European Pharmaceutical Contractor
|
Until recently the idea of outsourcing pharmacovigilance activities fell outside the comfort zone of all but a few pharmaceutical companies. This was in the main due to fear of the legal ramifications if the outsourcing partner 'got it wrong', and a reluctance to be the first to adopt the outsourcing model. It was also a reflection of the limited choice of both service providers and scope of services available at the time. In 1997 one of the authors, while working for a virtual development company, systematically examined the provision of such services and could identify only a few companies capable of meeting fully outsourced pharmacovigilance requirements.
In contrast, today's marketplace offers a wide range of pharmacovigilance services provided by both large and small companies. These may form part of a suite of services offered by CROs, be the core business of specialist companies, or form part of the expertise available through the growing network of freelance individuals, many of whom are former pharmaceutical company employees.
This growth in the services available for pharmacovigilance outsourcing has been driven by the annual increase in the volume of data generated both in terms of number of individual adverse event case reports and contributing organisations. This has prompted both the regulatory authorities and the pharmaceutical industry to seek more efficient methods of processing product adverse event data with the goal of both improving public safety and reducing the cost overhead for marketing and support of pharmaceutical products in the European Community and beyond.
|
Read full article >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
 |

 |
Industry Events |
 |
Line Clearance in Pharmaceutical Packaging & Manufacturing
5 February 2009, Manchester, UK
More info >>
|
|
 |
News and Press Releases |
 |
Financial Times hosts the Global Pharmaceutical and Biotechnology Conference
13th November 2008
More info >> |
|
|